Ibuprofen + Paracetamol + DicyclomineThird Party Manufacturing in India

Ibuprofen + Paracetamol + Dicyclomine is a triple combination tablet designed for the symptomatic relief of abdominal pain and cramping. Ibuprofen works by reversibly inhibiting cyclooxygenase-1 and cyclooxygenase-2 enzymes, which reduces the conversion of arachidonic acid into prostaglandins and thromboxanes. Lower prostaglandin levels decrease inflammation, pain signalling, and fever at peripheral and central sites. Paracetamol acts primarily within the central nervous system, where it inhibits a variant of the COX enzyme (COX-3) and modulates descending serotonergic pain pathways. It also influences cannabinoid receptors and the nitric oxide pathway, contributing to its analgesic and antipyretic effects without significant peripheral anti-inflammatory activity. Dicyclomine is a muscarinic acetylcholine receptor antagonist that blocks the action of acetylcholine at parasympathetic nerve endings in the gastrointestinal tract. This produces a direct smooth muscle relaxant effect on the stomach, intestines, and biliary tract, relieving visceral spasms and colicky pain. Together, the three components provide a multimodal approach to pain relief: Ibuprofen targets inflammation, Paracetamol addresses centrally mediated pain perception, and Dicyclomine resolves muscular spasms. This synergistic combination is particularly effective for conditions involving both inflammatory pain and smooth muscle spasm, offering faster and more complete relief than single-agent therapy.

Therapeutic Uses

Ibuprofen + Paracetamol + Dicyclomine is prescribed for the treatment of:

• Abdominal pain and cramping: The antispasmodic action of Dicyclomine relieves smooth muscle spasms in the gastrointestinal tract, providing rapid relief from colicky abdominal pain.
• Dysmenorrhea: The combination of an NSAID and an antispasmodic effectively manages menstrual cramps by reducing both prostaglandin-mediated uterine contractions and inflammatory pain.
• Irritable bowel syndrome (IBS): Dicyclomine reduces bowel hypermotility and associated cramping, while Ibuprofen and Paracetamol address accompanying pain.
• Gastroenteritis-associated pain: The triple action helps manage the pain and cramping that accompany viral or bacterial gastrointestinal infections.
• Biliary colic: Dicyclomine relaxes the smooth muscle of the biliary tract, offering symptomatic relief in mild biliary spasm.

Why Manufacturers Choose Ibuprofen + Paracetamol + Dicyclomine

This triple combination is one of the highest-volume formulations in the Indian analgesic market, driven by the widespread prevalence of abdominal pain and dysmenorrhea across all demographics. The combination has proven synergism — each component addresses a different pain pathway — which translates to superior patient outcomes and strong prescriber preference. Indian pharmaceutical manufacturers favour this combination because the active ingredients are well-characterised, readily available from multiple API suppliers, and stable in fixed-dose tablet form. The WHOGMP compliant manufacturing process is standard, and the tablet enjoys year-round demand with no seasonal variation. The combination also has strong export potential to Southeast Asian, African, and Middle Eastern markets where abdominal pain and dysmenorrhea are commonly treated with this class of medication. This makes Ibuprofen + Paracetamol + Dicyclomine one of the most sought-after combinations for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.